Glenmark Pharmaceuticals to pay $30M in US antitrust case

Glenmark Pharmaceuticals' US subsidiary will pay $29.6 million to resolve antitrust and consumer protection claims over alleged generic drug price-fixing in the United States.

Raccontata danewsbytesapp.com